alpha-Neup5Ac-(2--3)-beta-D-Galp-(1--4)-[alpha-L-Fucp-(1--3)]-D-GlcpNAc and Neoplasms

alpha-Neup5Ac-(2--3)-beta-D-Galp-(1--4)-[alpha-L-Fucp-(1--3)]-D-GlcpNAc has been researched along with Neoplasms* in 28 studies

Reviews

10 review(s) available for alpha-Neup5Ac-(2--3)-beta-D-Galp-(1--4)-[alpha-L-Fucp-(1--3)]-D-GlcpNAc and Neoplasms

ArticleYear
The physiological and pathological roles and applications of sialyl Lewis x, a common carbohydrate ligand of the three selectins.
    Glycoconjugate journal, 2020, Volume: 37, Issue:2

    In the past decades, the roles of carbohydrates in living organisms and their potential use in many fields have been extensively investigated. Sialyl Lewis x (sLe

    Topics: Animals; Biomarkers, Tumor; Drug Carriers; Humans; Neoplasms; Selectins; Sialyl Lewis X Antigen

2020
[Glycan ligand specificity of killer lectin receptors].
    Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan, 2012, Volume: 132, Issue:6

    Sialyl Lewis X (sLeX) antigen, Neu5Acα2,3Galβ1,4(Fucα1,3)GlcNAc-R, is expressed on the glycoproteins in sera or the surface of the cells and the expression of sLeX is enhanced in various conditions such as the inflammation and cancer. SLeX in the serum is utilized as a tumor marker. To clarify the roles of sLeX on secreted glycoproteins in vivo, we investigate the regulation of natural killer (NK) cell-dependent cytotoxicity through sLeX. NK cells express many receptors to kill the target cells such as cancerous cells and non-self, and their protein ligands have been elucidated. Of the killer lectin-like receptors (KLRs) on NK cells, several have been reported to recognize glycans. Using recombinant extracellular domains of KLRs (rKLRs: rNKG2A, C, D and rCD94), we evaluated their glycan ligand specificity and binding affinities using EIA methods. We clarified that all of these rKLRs can bind to high sLeX-expressing glycoprotein and heparin, heparan sulfate and highly sulfated polysaccharides and that glycan binding sites on NKG2D are mostly overlapped with those of protein ligands. In this review, we show the recent findings concerning the glycan ligands of these KLRs.

    Topics: Animals; Biomarkers; Cytotoxicity, Immunologic; Glycoproteins; Heparin; Heparitin Sulfate; Humans; Inflammation; Killer Cells, Natural; Lewis X Antigen; Ligands; Mice; Neoplasms; Polysaccharides; Protein Binding; Receptors, NK Cell Lectin-Like; Sialyl Lewis X Antigen

2012
Regulation of the metastatic cell phenotype by sialylated glycans.
    Cancer metastasis reviews, 2012, Volume: 31, Issue:3-4

    Tumor cells exhibit striking changes in cell surface glycosylation as a consequence of dysregulated glycosyltransferases and glycosidases. In particular, an increase in the expression of certain sialylated glycans is a prominent feature of many transformed cells. Altered sialylation has long been associated with metastatic cell behaviors including invasion and enhanced cell survival; however, there is limited information regarding the molecular details of how distinct sialylated structures or sialylated carrier proteins regulate cell signaling to control responses such as adhesion/migration or resistance to specific apoptotic pathways. The goal of this review is to highlight selected examples of sialylated glycans for which there is some knowledge of molecular mechanisms linking aberrant sialylation to critical processes involved in metastasis.

    Topics: Animals; Antigens, Tumor-Associated, Carbohydrate; Cell Movement; Glycosylation; Humans; Integrins; Lewis X Antigen; N-Acetylneuraminic Acid; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasms; Phenotype; Polysaccharides; Sialyl Lewis X Antigen

2012
Glycosylation defining cancer cell motility and invasiveness.
    Glycoconjugate journal, 2004, Volume: 20, Issue:1

    Topics: Carcinoma; Cell Adhesion Molecules; Cell Movement; Colorectal Neoplasms; Glycosylation; Humans; Integrins; Kalinin; Liver Neoplasms; Neoplasm Invasiveness; Neoplasms; Oligosaccharides; Sialyl Lewis X Antigen

2004
Carbohydrate-mediated cell adhesion in cancer metastasis and angiogenesis.
    Cancer science, 2004, Volume: 95, Issue:5

    Malignant transformation is associated with abnormal glycosylation, resulting in the synthesis and expression of altered carbohydrate determinants including sialyl Lewisa and sialyl Lewisx. The sialyl Lewisa and sialyl Lewisx determinants appear in the sera of patients with cancer, and are extensively utilized for serum diagnosis of cancers in Japan. Sialyl Lewisa and sialyl Lewisx are involved in selectin-mediated adhesion of cancer cells to vascular endothelium, and these determinants are thought to be closely associated with hematogenous metastasis of cancers. Recent progress in this area includes the following: 1. Substantial increases in solid clinical statistics that further confirm the contribution of these determinants in the progression of a wide variety of cancers; 2. Elucidation of the ligand specificity of the three family members of selectins and evaluation of the roles of these molecules in cancer cell adhesion; and 3. Advances in the study of the mechanism that leads to the enhanced expression of the sialyl Lewis(a/x) determinants in malignant cells. These recent results have confirmed that these determinants are not merely markers for cancers, but are functionally implicated in the malignant behavior of cancer cells. The results also suggested that the increase of these determinants in malignant cells is an inevitable consequence of the malignant transformation of cells. Considerable new knowledge has also been accumulated regarding the therapeutic implications for suppression of hematogenous metastasis targeting this cell adhesion system.

    Topics: Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; CA-19-9 Antigen; Carbohydrate Metabolism; Cell Adhesion; Cell Transformation, Neoplastic; Endothelium; Gangliosides; Humans; Lewis Blood Group Antigens; Neoplasm Metastasis; Neoplasms; Neovascularization, Pathologic; Oligosaccharides; Selectins; Sialyl Lewis X Antigen

2004
The discovery, biology, and drug development of sialyl Lea and sialyl Lex.
    Archives of biochemistry and biophysics, 2004, Jun-15, Volume: 426, Issue:2

    The discoveries of sialylated, fucosylated lacto-, and neolacto-type carbohydrate structures were accomplished with the aid of analytical methods and monoclonal antibodies such as the immunostaining of thin layer chromatograms. Based on the use of such antibodies, these structures, notably sialyl Le(a) and sialyl Le(x), were demonstrated to be highly expressed in many malignant cancers. A diagnostic assay using one of these antibodies (CA19-9) is now established as one of the more commonly used assays for pancreatic and gastrointestinal cancers worldwide. Upon further study, several laboratories have demonstrated that the level of expression of these carbohydrate tumor markers is also positively correlated with patient survival and is a prognostic indicator of metastatic disease. Concurrent with this finding, both sialyl Le(a) and sialyl Le(x) were shown to bind to a family of carbohydrate-binding proteins involved in the extravasation of cells from the bloodstream, called the selectins. Thus, sialyl Le(a) and sialyl Le(x) expressed on cell surfaces play functional roles in medical conditions that require extravasation of cells from the bloodstream which include a wide range of inflammatory diseases and cancer metastasis. Many studies have confirmed the function of sialyl Le(a) and sialyl Le(x) in animal models of these diseases and the inhibition of binding of sialyl Le(a) and sialyl Le(x) to the selectins is a validated drug target in the pharmaceutical industry. Thus, a new class of drugs, arising from the field of glycobiology, is based on the rational design of small molecule drugs that mimic the structures sialyl Le(a) and sialyl Le(x) and can potently inhibit their functional binding to the selectins.

    Topics: Animals; Binding Sites; Biomarkers, Tumor; CA-19-9 Antigen; Drug Design; Gangliosides; Humans; Inflammation; Macromolecular Substances; Models, Chemical; Models, Molecular; Molecular Conformation; Neoplasms; Oligosaccharides; Selectins; Sialyl Lewis X Antigen; Stereoisomerism; Structure-Activity Relationship

2004
Molecular mechanism for cancer-associated induction of sialyl Lewis X and sialyl Lewis A expression-The Warburg effect revisited.
    Glycoconjugate journal, 2004, Volume: 20, Issue:5

    Cell adhesion mediated by selectins and their carbohydrate ligands, sialyl Lewis X and sialyl Lewis A, figures heavily in cancer metastasis. Expression of these carbohydrate determinants is markedly enhanced in cancer cells, but the molecular mechanism that leads to cancer-associated expression of sialyl Lewis X/A has not been well understood. Results of recent studies indicated involvement of two principal mechanisms in the accelerated expression of sialyl Lewis X/A in cancers; 'incomplete synthesis' and ' neo synthesis.' As to 'incomplete synthesis,' we have recently found further modified forms of sialyl Lewis X and sialyl Lewis A in non-malignant colonic epithelium, which have additional 6-sulfation or 2 --> 6 sialylation. The impairment of GlcNAc 6-sulfation and 2 --> 6 sialylation upon malignant transformation leads to accumulation of sialyl Lewis X/A in colon cancer cells. Epigenetic changes such as DNA methylation and/or histone deacetylation are suggested to lie behind such incomplete synthesis. As to the mechanism called ' neo synthesis,' recent studies have indicated that cancer-associated alterations in the sugar transportation and intermediate carbohydrate metabolism play important roles. Cancer cells are known to exhibit a metabolic shift from oxidative to elevated anaerobic glycolysis (Warburg effect), which is correlated with the increased gene expression of sugar transporters and glycolytic enzymes induced by common cancer-specific genetic alterations. The increased sialyl Lewis X/A expression in cancer is a link in the chains of these events because our recent results indicated that these events accompany transcriptional induction of a set of genes closely related to its expression.

    Topics: Animals; Biomarkers, Tumor; CA-19-9 Antigen; Cell Transformation, Neoplastic; Gene Expression Regulation, Neoplastic; Humans; Neoplasms; Oligosaccharides; Sialyl Lewis X Antigen

2004
[Human fucosyltransferases: tissue distribution of blood group antigens, cancer-associated antigens and fucosyltransferases].
    Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme, 1998, Volume: 43, Issue:16 Suppl

    Topics: Animals; Antigens, Tumor-Associated, Carbohydrate; CA-19-9 Antigen; Cloning, Molecular; Fucosyltransferases; Gangliosides; Humans; Lewis Blood Group Antigens; Neoplasms; Oligosaccharides; Sialyl Lewis X Antigen; Substrate Specificity; Tissue Distribution

1998
Carbohydrate-mediated cell adhesion involved in hematogenous metastasis of cancer.
    Glycoconjugate journal, 1997, Volume: 14, Issue:5

    The carbohydrate determinants, sialyl Lewis A and sialyl Lewis X, which are frequently expressed on human cancer cells, serve as ligands for a cell adhesion molecule of the selectin family, E-selectin, which is expressed on vascular endothelial cells. These carbohydrate determinants are involved in the adhesion of cancer cells to vascular endothelium and thus contribute to hematogenous metastasis of cancer. The initial adhesion mediated by these molecules triggers activation of integrin molecules through the action of several cytokines and leads to the extravasation of cancer cells. Cancer cells also produce humoral factors that facilitate E-selectin expression on endothelial cells. The degree of expression of the carbohydrate ligands at the surface of cancer cells is well correlated with the frequency of hematogenous metastasis and prognostic outcome of patients with cancers. The alteration of glycosyltransferase activities that leads to the enhanced expression of these carbohydrate ligands on cancer cell surface are currently being investigated.

    Topics: Animals; Biomarkers, Tumor; Cell Adhesion; E-Selectin; Glycosyltransferases; Humans; Lewis X Antigen; Models, Biological; Neoplasm Metastasis; Neoplasms; Oligosaccharides; P-Selectin; Prognosis; Sialyl Lewis X Antigen

1997
In vitro experimental studies of sialyl Lewis x and sialyl Lewis a on endothelial and carcinoma cells: crucial glycans on selectin ligands.
    Glycoconjugate journal, 1997, Volume: 14, Issue:5

    Extravasation from the blood of malignant tumour cells that form metastasis and leukocytes that go into tissues require contact between selectins and their sialyl Lewis x and sialyl Lewis a (sLe(x) and sLe(a) respectively) decorated ligands. Endothelial cells have been shown to express sLe(x) epitopes in lymph nodes and at sites of inflammation, and this is crucial for the selectin-dependent leukocyte traffic. Besides the ability to synthesize sLe(x) on sialylated N-acetyllactosamine via the action of alpha(1,3)fucosyltransferase(s), endothelial cells can also degrade sLe(x) to Lewis x through the action of alpha(2,3)sialidase(s). In addition, several epithelial tumors possess the machinery to synthesize sLe(x), which facilitates their adhesion to endothelial E- and P-selectin.

    Topics: Animals; Carbohydrate Conformation; Carbohydrate Sequence; Endothelium, Vascular; Fucosyltransferases; Humans; Inflammation; Lymph Nodes; Molecular Sequence Data; Neoplasms; Neuraminidase; Oligosaccharides; Sialyl Lewis X Antigen

1997

Other Studies

18 other study(ies) available for alpha-Neup5Ac-(2--3)-beta-D-Galp-(1--4)-[alpha-L-Fucp-(1--3)]-D-GlcpNAc and Neoplasms

ArticleYear
Toward α-1,3/4 fucosyltransferases targeted drug discovery: In silico uncovering of promising natural inhibitors of fucosyltransferase 6.
    Journal of cellular biochemistry, 2023, Volume: 124, Issue:8

    Sialyl Lewis X (sLe

    Topics: Drug Discovery; Fucosyltransferases; Glycosylation; Humans; Male; Neoplasms; Sialyl Lewis X Antigen

2023
Triazole-linked fluorescent bisboronic acid capable of selective recognition of the Lewis Y antigen.
    Bioorganic & medicinal chemistry letters, 2017, 05-01, Volume: 27, Issue:9

    Cell surface carbohydrates of the Lewis blood group antigens, Lewis X (Le

    Topics: Anthracenes; Antigens, Tumor-Associated, Carbohydrate; Boronic Acids; Cell Line, Tumor; Fluorescent Dyes; Humans; Lewis Blood Group Antigens; Microscopy, Fluorescence; Neoplasms; Oligosaccharides; Sialyl Lewis X Antigen; Triazoles

2017
Regulations of glycolipid: XI. glycosyltransferase (GSL: GLTs) genes involved in SA-LeX and related GSLs biosynthesis in carcinoma cells by Biosimilar apoptotic agents: potential anticancer drugs.
    Advances in experimental medicine and biology, 2015, Volume: 842

    Topics: Antineoplastic Agents; Apoptosis; Biosimilar Pharmaceuticals; Cell Line, Tumor; Decorin; Gangliosides; Glycolipids; Glycosyltransferases; Humans; Inhibitory Concentration 50; Lewis X Antigen; MCF-7 Cells; Microscopy, Fluorescence; Neoplasms; Sialyl Lewis X Antigen; Triterpenes

2015
Increased fucosylation has a pivotal role in invasive and metastatic properties of head and neck cancer stem cells.
    Oncotarget, 2015, Jan-01, Volume: 6, Issue:1

    Oral squamous cell carcinoma (OSCC) is an aggressive malignancy with high mortality rates. Major challenges for OSCC management include development of resistance to therapy and early formation of distant metastases. Cancer stem cells (CSCs) have emerged as important players in both pathologic mechanisms. Increased fucosylation activity and increased expression of fucosylated polysaccharides, such as Sialyl Lewis X (SLex), are associated with invasion and metastasis. However, the role of fucosylation in CSCs has not been elucidated yet. We used the spheroid culture technique to obtain a CSC-enriched population and compared orospheres with adherent cells. We found that orospheres expressed markers of CSCs and metastasis at higher levels, were more invasive and tumorigenic, and were more resistant to cisplatin/radiation than adherent counterparts. We found fucosyltransferases FUT3 and FUT6 highly up-regulated, increased SLex expression and increased adhesion by shear flow assays in orospheres. Inhibition of fucosylation negatively affected orospheres formation and invasion of oral CSCs. These results confirm that orospheres are enriched in CSCs and that fucosylation is of paramount importance for CSC invasion. In addition, SLex may play a key role in CSC metastasis. Thus, inhibition of fucosylation may be used to block CSCs and metastatic spread.

    Topics: Animals; Antineoplastic Agents; Biomarkers, Tumor; Cell Adhesion; Cisplatin; Dose-Response Relationship, Drug; Drug Resistance, Neoplasm; Female; Fucose; Head and Neck Neoplasms; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplasm Invasiveness; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Neoplastic Stem Cells; Oligosaccharides; Shear Strength; Sialyl Lewis X Antigen; Stress, Mechanical

2015
Total synthesis of a sialyl Lewis(x) derivative for the diagnosis of cancer.
    Carbohydrate research, 2014, Jan-13, Volume: 383

    The total synthesis of aminoethyl glycoside of sialyl Lewis(x) (sLe(x)) is described. A galactose donor was condensed with a diol of glucosamine to afford regioselectively a β1,4 linked disaccharide, which was further stereoselectively fucosylated to provide a protected Lewis(x) trisaccharide. After chemical modification, the trisaccharide was sialylated to give regio- and stereoselectively an azidoethyl glycoside of sLe(x). Finally, deprotection and azide reduction afforded the target compound. This compound will be coupled with protein and then be used to conduct further preclinical studies for the diagnosis of cancer.

    Topics: E-Selectin; Glucosamine; Humans; Ligands; Neoplasms; Oligosaccharides; Sialyl Lewis X Antigen; Trisaccharides

2014
In situ recognition of cell-surface glycans and targeted imaging of cancer cells.
    Scientific reports, 2013, Volume: 3

    Fluorescent sensors capable of recognizing cancer-associated glycans, such as sialyl Lewis X (sLe(x)) tetrasaccharide, have great potential for cancer diagnosis and therapy. Studies on water-soluble and biocompatible sensors for in situ recognition of cancer-associated glycans in live cells and targeted imaging of cancer cells are very limited at present. Here we report boronic acid-functionalized peptide-based fluorescent sensors (BPFSs) for in situ recognition and differentiation of cancer-associated glycans, as well as targeted imaging of cancer cells. By screening BPFSs with different structures, it was demonstrated that BPFS₁ with a FRGDF peptide could recognize cell-surface glycan of sLe(x) with high specificity and thereafter fluorescently label and discriminate cancer cells through the cooperation with the specific recognition between RGD and integrins. The newly developed peptide-based sensor will find great potential as a fluorescent probe for cancer diagnosis.

    Topics: Animals; Cell Line, Tumor; Cell Membrane; Flow Cytometry; Fluorescent Dyes; Humans; Integrins; Ligands; Microscopy, Fluorescence; Molecular Imaging; Molecular Structure; Neoplasms; Oligosaccharides; Polysaccharides; Sialyl Lewis X Antigen

2013
Identification of new cancer biomarkers based on aberrant mucin glycoforms by in situ proximity ligation.
    Journal of cellular and molecular medicine, 2012, Volume: 16, Issue:7

    Mucin glycoproteins are major secreted or membrane-bound molecules that, in cancer, show modifications in both the mucin proteins expression and in the O-glycosylation profile, generating some of the most relevant tumour markers in clinical use for decades. Thus far, the identification of these biomarkers has been based on the detection of either the protein or the O-glycan modifications. We therefore aimed to identify the combined mucin and O-glycan features, that is, specific glycoforms, in an attempt to increase specificity of these cancer biomarkers. Using in situ proximity ligation assays (PLA) based on existing monoclonal antibodies directed to MUC1, MUC2, MUC5AC and MUC6 mucins and to cancer-associated carbohydrate antigens Tn, Sialyl-Tn (STn), T, Sialyl-Le(a) (SLe(a)) and Sialyl-Le(x) (SLe(x)) we screened a series of 28 mucinous adenocarcinomas from different locations (stomach, ampulla of Vater, colon, lung, breast and ovary) to detect specific mucin glycoforms. We detected Tn/STn/SLe(a)/SLe(x)-MUC1 and STn/SLe(a)/SLe(x)-MUC2 glycoforms in ≥50% of the cases, with a variable distribution among organs. Some new glycoforms-T/SLe(a)-MUC2, STn/T/SLe(a) SLe(x)-MUC5AC and STn/T/SLe(a)/SLe(x)-MUC6-were identified for the first time in the present study in a variable percentage of cases from different organs. In conclusion, application of the PLA technique allowed sensitive detection of specific aberrant mucin glycoforms in cancer, increasing specificity to the use of antibodies either to the mucin protein backbone or to the O-glycan haptens alone.

    Topics: Adenocarcinoma, Mucinous; Antigens, Tumor-Associated, Carbohydrate; Biomarkers, Tumor; Breast; CA-19-9 Antigen; Colon; Fluorescent Antibody Technique; Gangliosides; Glycosylation; Humans; Immunohistochemistry; Lung; Mucin 5AC; Mucin-1; Mucin-2; Mucin-6; Neoplasms; Oligosaccharides; Sialyl Lewis X Antigen

2012
Development of an active targeting liposome encapsulated with high-density colloidal gold for transmission electron microscopy.
    Journal of electron microscopy, 2011, Volume: 60, Issue:1

    Active targeting of the liposome is an attractive strategy for drug delivery and in vivo bio-imaging. We previously reported the specific accumulation of Sialyl Lewis X (SLX) liposome to inflamed tissue in arthritic model mice or tumor-bearing mice. SLX-liposome encapsulation with fluorescent substances allows for the visualization of these liposomes by the time-dependent transvascular accumulation of fluorescent signals in the histological sections. In the present study, we developed a new SLX-liposome encapsulated with colloidal gold for transmission electron microscopic observation. We herein describe the characterization of the colloidal gold-loaded SLX-liposomes and demonstrate its specific targeting to the endothelial cells of tumor blood vessels in tumor-bearing mice.

    Topics: Animals; Arthritis; Drug Delivery Systems; Endothelial Cells; Female; Gold Colloid; Inflammation; Liposomes; Mice; Mice, Inbred BALB C; Microscopy, Electron, Transmission; Models, Animal; Neoplasms; Oligosaccharides; Sialyl Lewis X Antigen

2011
Flow cytometric assay for quantitative and qualitative evaluation of adhesive interactions of tumor cells with endothelial cells.
    Microvascular research, 2008, Volume: 76, Issue:2

    The purpose of the study was to develop a flow cytometric assay for quantitative determination of adhesive interactions of human endothelial cells (ECs) with tumor cells. EC lines established from human lymph node, appendix, lung, skin and intestine microvessels, labeled with PKH26-GL fluorescent dye, were grown to confluency in 24-well TC plates. Human colon adenocarcinoma cell suspension was overlaid onto labeled ECs, and allowed to adhere for 20 min at 4 degrees C under static conditions. Non-adhering cells were collected first, and adhering tumor cells together with ECs were detached from the culture plate. Collected cell fractions were evaluated by flow cytometry. Results were re-calculated as a ratio (R) of adhering colon carcinoma cells per one EC. We demonstrated that immortalized human microvascular ECs preserved their organ specificity. Colon carcinoma cells adhere preferentially to ECs of intestine origin. The immunofluorescent staining of adhering and non-adhering cancer cell subpopulations has revealed an augmented level of Lewis(x) antigen on adhering cancer cells. The organ specificity of endothelial cell interactions with colon carcinoma cells demonstrated in static conditions was verified and confirmed with flow adhesion assay. The method elaborated is suitable for quantifying of tumor cells adhering to ECs, with simultaneous evaluation of cell surface phenotypic markers of both partner cells participating in adhesive interactions. Validated by comparison to dynamic shear stress adhesion assay in blood flow reconstituted conditions this assay greatly facilitates evaluation of tumor cell-endothelial cell mutual interactions taking place during metastatic process.

    Topics: Cell Adhesion; Cell Communication; Cell Line, Tumor; Cells, Cultured; Coculture Techniques; Colonic Neoplasms; Endothelial Cells; Flow Cytometry; Fluorescent Antibody Technique; Humans; Intestine, Small; Lewis X Antigen; Lung; Lymph Nodes; Neoplasms; Oligosaccharides; Sialyl Lewis X Antigen; Skin

2008
Effect of surface modified liposomes on the aggregation of platelets and tumor cells.
    Thrombosis and haemostasis, 2005, Volume: 94, Issue:2

    Metastasis is still the most serious reason for the high mortality of cancer patients. It is a complex process in which platelets play a crucial role. Several attempts have been performed to inhibit the metastatic process, some of these using modified liposomes. The aggregation behaviour of human platelets and HT29 colon carcinoma cells in the presence of liposomes with a modified surface has been investigated in the present study. Liposomes (PC/CH/DMPE) were unmodified, sterically stabilized by polyethylene glycol (PEG-DSPE), or equipped with the carbohydrate ligand sialyl Lewis(X) (conjugated to PEG-DMPE or DMPE as anchor) intended to specifically compete with ligands expressed by HT29 cells. We found in vitro that an addition of surface modified liposomes to human platelets in plasma caused an up to 2.9-fold increase in platelet aggregation. In addition, when HT29 tumor cells were mixed with platelets and surface modified liposomes, the number of tumor cells found in aggregates increased significantly from 8.3 % (only tumor cells) to 30.2 %. This result was supported by fluorescence micrographs demonstrating a strong association of platelets and liposomes around the tumor cells. In addition, a clear decrease in number and a change in the distribution of metastases after intravenous injection of HT29 cells in combination with liposomes was observed in vivo. While in control mice metastases in lung, liver and in intestine were prevailing, liposomal treatment resulted in a new localization of metastases in muscles. Taking together, the ability of surface modified liposomes to enhance aggregate formation of platelets and tumor cells has been demonstrated for the first time. The capability of these vesicles to interfere with the metastatic process might have implications for the use of such liposomes for therapeutic applications.

    Topics: Blood Platelets; Cell Line, Tumor; Cell Separation; Drug Carriers; Drug Delivery Systems; Flow Cytometry; Humans; Ligands; Liposomes; Microscopy, Fluorescence; Neoplasm Metastasis; Neoplasm Transplantation; Neoplasms; Oligosaccharides; Phosphatidylcholines; Phosphatidylethanolamines; Platelet Aggregation; Polyethylene Glycols; Protein Binding; Sialyl Lewis X Antigen; Surface Properties; Time Factors

2005
Hypoxia induces adhesion molecules on cancer cells: A missing link between Warburg effect and induction of selectin-ligand carbohydrates.
    Proceedings of the National Academy of Sciences of the United States of America, 2004, May-25, Volume: 101, Issue:21

    Cancer cells undergo distinct metabolic changes to cope with their hypoxic environment. These changes are achieved at least partly by the action of transcriptional factors called hypoxia-inducible factors (HIFs). We investigated gene expression in cultured human colon cancer cells induced by hypoxic conditions with special reference to cell-adhesion molecules and carbohydrate determinants having cell-adhesive activity by using DNA-microarray and RT-PCR techniques. Hypoxic culture of colon cancer cells induced a marked increase in expression of selectin ligands, the sialyl Lewis x and sialyl Lewis a determinants at the cell surface, which led to a definite increase in cancer cell adhesion to endothelial E-selectin. The transcription of genes for fucosyltransferase VII (FUT7), sialyltransferase ST3Gal-I (ST3O), and UDP-galactose transporter-1 (UGT1), which are all known to be involved in the synthesis of the carbohydrate ligands for E-selectin, was significantly induced in cancer cells by hypoxic culture. In addition, a remarkable induction was detected in the genes for syndecan-4 (SDC4) and alpha5-integrin (ITGA5), the cell-adhesion molecules involved in the enhanced adhesion of cancer cells to fibronectin. The transcriptional induction by hypoxia was reproduced in the luciferase-reporter assays for these genes, which were significantly suppressed by the co-transfection of a dominant-negative form of HIF. These results indicate that the metabolic shifts of cancer cells partly mediated by HIFs significantly enhance their adhesion to vascular endothelial cells, through both selectin- and integrin-mediated pathways, and suggest that this enhancement further facilitates hematogenous metastasis of cancers and tumor angiogenesis.

    Topics: Antigens, Tumor-Associated, Carbohydrate; Carbohydrate Metabolism; Carbohydrates; Cell Adhesion; Cell Adhesion Molecules; Cell Culture Techniques; Cell Line, Tumor; Gene Expression Regulation, Neoplastic; Genes, Reporter; Humans; Hypoxia; Integrin alpha5; Lewis Blood Group Antigens; Ligands; Luciferases; Membrane Glycoproteins; Neoplasms; Oligosaccharides; Promoter Regions, Genetic; Proteoglycans; RNA, Messenger; Selectins; Sialyl Lewis X Antigen; Syndecan-4; Transcription, Genetic

2004
Glycobiology. Turning sweet on cancer.
    Science (New York, N.Y.), 2003, Jul-11, Volume: 301, Issue:5630

    Topics: Animals; Carbohydrate Metabolism; Diagnostic Imaging; Disaccharides; Glycosylation; Humans; Magnetic Resonance Imaging; Mice; Neoplasm Metastasis; Neoplasms; Oligosaccharides; Selectins; Sialic Acids; Sialyl Lewis X Antigen

2003
Expression of gastric gland mucous cell-type mucin in normal and neoplastic human tissues.
    The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society, 2003, Volume: 51, Issue:12

    Gastric gland mucous cells produce class III mucin, which is also found in Brunner's glands and mucous glands along the pancreaticobiliary tract, and in metaplasia and adenocarcinomas differentiating towards gastric mucosa. Recently, we showed that class III mucin possesses GlcNAcalpha1-->4Galbeta-->R, formed by alpha1,4-N-acetylglucosaminyltransferase (alpha4GnT). Examining the tissue-specific expression of mucin epitopes is useful to clarify cell-lineage differentiation and to identify the site of origin of metastatic carcinomas in histological specimens. Formalin-fixed, paraffin-embedded tissue sections from esophagus, stomach, colon, liver, pancreas, lung, kidney, prostate, breast, and salivary gland resected for carcinoma, as well as salivary gland adenoma, colon adenoma, and metastatic adenocarcinoma of lymph nodes from stomach, pancreas, colon, and breast, were immunostained for MUC6, alpha4GnT, and GlcNAcalpha1-->4Galbeta-->R. These were all expressed in normal, metaplastic, and adenocarcinoma tissues of stomach, pancreas, and bile duct, and in pulmonary mucinous bronchioloalveolar carcinomas. Cells expressing alpha4GnT uniformly expressed GlcNAcalpha1-->4Galbeta-->R. Only MUC6 was expressed in normal salivary glands, pancreas, seminal vesicles, renal tubules, and colon adenomas, and in normal tissue and adenocarcinomas of prostate and breast. No tissues showed immunoreactivity for alpha4GnT alone. Immunohistochemistry (IHC) profiles were similar for metastatic carcinomas and primary carcinoma tissues. The IHC profiles for MUC6, alpha4GnT, and GlcNAcalpha1-->4Galbeta-->R may be diagnostically relevant.

    Topics: Acetylglucosamine; Adenocarcinoma; Adenoma; Cell Differentiation; Gastric Mucosa; Humans; Immunohistochemistry; Lymphatic Metastasis; Mucin-6; Mucins; N-Acetylglucosaminyltransferases; Neoplasms; Oligosaccharides; Organ Specificity; Sialyl Lewis X Antigen; Stomach Neoplasms

2003
Analysis of serum Sialyl-Lewis(x) antigen levels in acute leukemias, myelodysplastic syndromes, myeloproliferative disorders and malignant lymphomas.
    Leukemia & lymphoma, 2002, Volume: 43, Issue:9

    Topics: Antigens; Humans; Leukemia; Myelodysplastic Syndromes; Myeloproliferative Disorders; Neoplasms; Oligosaccharides; Sialyl Lewis X Antigen

2002
Surface carbohydrates involved in the adhesive interactions of metastatic cells.
    Biochemical Society transactions, 1997, Volume: 25, Issue:1

    Topics: Animals; CA-19-9 Antigen; Cell Adhesion; Cell Membrane; E-Selectin; Female; Galactosides; Galectin 1; Gangliosides; Glycoconjugates; Hemagglutinins; Humans; Hyaluronan Receptors; Hyaluronic Acid; Lectins; Lewis Blood Group Antigens; Neoplasm Metastasis; Neoplasms; Oligosaccharides; Ovarian Neoplasms; Sialyl Lewis X Antigen

1997
Elevated sialyl Lewis X-i antigen levels in pleural effusions in patients with carcinomatous pleuritis.
    Internal medicine (Tokyo, Japan), 1997, Volume: 36, Issue:10

    The levels of sialyl Lewis X-i antigen (SLX), which is one of the cancer-associated carbohydrate antigens, were evaluated in 83 malignant and 46 benign pleural effusions. SLX levels in pleural effusion due to lung adenocarcinoma were significantly higher than those due to benign diseases (p < 0.0001), lung cancer other than adenocarcinoma (p = 0.0052), and adenocarcinoma originating from other organs (p = 0.0492). According to receiver operating characteristic (ROC) curve analysis, the optimal cut-off level in the discrimination between malignant and benign pleural effusions was 92 U/ml, which gave a sensitivity of 57.1% and a specificity of 77.8%. The cut-off level of pleural effusion in patients with carcinomatous pleuritis might be higher than that of serum (38 U/ml).

    Topics: Adenocarcinoma; Biomarkers, Tumor; Biopsy; Carcinoma, Small Cell; Carcinoma, Squamous Cell; Female; Humans; Lung Neoplasms; Male; Neoplasms; Oligosaccharides; Pleural Effusion, Malignant; Pleurisy; Radioimmunoassay; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Sialyl Lewis X Antigen

1997
Specificity analysis of three clonal and five non-clonal alpha 1,3-L-fucosyltransferases with sulfated, sialylated, or fucosylated synthetic carbohydrates as acceptors in relation to the assembly of 3'-sialyl-6'-sulfo Lewis x (the L-selectin ligand) and r
    Biochemistry, 1996, Jul-09, Volume: 35, Issue:27

    Unique specificities of the cloned alpha 1,3-L-fucosyltransferases (FTs), FT III (Lewis type), FT IV (myeloid type), and FT V (plasma type), and the alpha 1,3-FTs of Colo 205 (colon carcinoma), HL 60 (myeloid), B142 (lymphoid), EKVX (lung carcinoma), and calf mesenteric lymph nodes (CMLN) were discerned with sulfated, sialylated, and/or fucosylated Gal beta 1,3/4GlcNAc beta-based acceptor moieties. (a) FT V was 1.0-, 20.8-, and 4.6-fold active in forming Lewis x, Lewis y, and 3'-alpha-galactosyl Lewis x, respectively. (b) FT III and FT V formed approximately 4-fold 3'-sulfo Lewis x, as compared to 3'-sialyl Lewis x. (c) FT IV showed great efficiency in forming 3'-sulfo Lewis x (249%) and Lewis x (345%) in mucin-type branched chains. (d) FT III, FT IV, and FT V formed 19%, 62%, and 47% 6-sulfo Lewis x as compared to Lewis x. (e) 6'-Sulfo Lewis x and 3'-sialyl-6'-sulfo Lewis x (GLYCAM ligand) were not synthesized from their immediate precursors by FT III, FT IV, or FT V. (f) FT III, FT IV, and FT V were 311%, 9%, and 188% active, respectively, with 2'-fucosyl lactose but were not active with 2'- fucosyl-6'-sulfo lactose. (g) FT III and FT V were 7.0- and 0.5-fold active in forming Lewis a as compared to Lewis x, whereas, FT IV was inactive. (h) FT III was -2.0-fold more active in forming 3'-alpha-galactosyl Lewis a than Lewis b. (i) FT III synthesized 6-sialyl Lewis a (40% efficiency as compared to Lewis a) from 6-sialyl type 1. (j) FT III did not act on 6'-sulfo or 6'-sialyl type 1 but was 106% and 22% active with 3'-sulfo and 6-sulfo type 1, respectively. (k) The Colo 205 FT activities with type 1 compounds almost paralleled that of FT III except for the low activity (9%) with Gal beta 1,3(NeuAc alpha 2, 6)GlcNAc beta-O-Bn, but with type 2 considerable differences between Colo 205 FT and FT III were noticed. (l) The alpha 1,3-FTs of CMLN, HL60, B142, and EKVX were 1.2-1.7 times active with Fuc alpha 1,2Gal beta 1,4GlcNAc beta- O-pNP and Gal alpha 1,3Gal beta 1,4 GlcNAc beta-O-Bn with respect to Gal beta 1,4GlcNAc beta-O-Al. (m) Both CMLN and HL60 FTs were 2-fold active with 3-sulfoGal beta 1,4GlcNAc in a mucin-type branch structure such as 3-sulfoGal beta 1,4GlcNAc beta 1,6(Gal beta 1,3)GalNAc alpha-O-Bn. (n) The 3'-sulfoLacNAc/acrylamide copolymer, either as an acceptor or as a competitive inhibitor, had the potential to distinguish myeloid type alpha 1,3-FT from the plasma type.

    Topics: Animals; Bone Marrow; Carbohydrate Sequence; Cattle; Cell Line; Fucosyltransferases; Humans; Lewis X Antigen; Lymph Nodes; Molecular Sequence Data; Neoplasms; Oligosaccharides; Recombinant Proteins; Sialyl Lewis X Antigen; Substrate Specificity

1996
Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells.
    Science (New York, N.Y.), 1990, Nov-23, Volume: 250, Issue:4984

    Endothelial leukocyte adhesion molecule-1 (ELAM-1) is an endothelial cell adhesion molecule that allows myeloid cells to attach to the walls of blood vessels adjacent to sites of inflammation. ELAM-1 recognizes the sialyl-Lewis X (sialyl-Lex) determinant, NeuAc alpha 2-3Gal beta 1-4(Fuc alpha 1-3)GlcNAc-, a granulocyte carbohydrate also found on the surface of some tumor cell lines. Binding of myeloid cells to soluble ELAM-1 is inhibited by a monoclonal antibody recognizing sialyl-Lex or by proteins bearing sialyl-Lex, some of which may participate in humoral regulation of myeloid cell adhesion. Stimulated granulocytes also release an inhibitor of ELAM-1 binding that can be selectively adsorbed by monoclonal antibody to sialyl-Lex.

    Topics: Amniotic Fluid; Antibodies, Monoclonal; Carbohydrate Sequence; Cell Adhesion; Cell Adhesion Molecules; Cell Membrane; E-Selectin; Endothelium, Vascular; Fucose; Fucosyltransferases; Granulocytes; Immunosorbent Techniques; Interleukin-1; Interleukin-8; Lewis X Antigen; Molecular Sequence Data; Neoplasms; Neuraminidase; Oligosaccharides; Orosomucoid; Sialyl Lewis X Antigen; Tumor Cells, Cultured

1990